Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Belgium

Belgium Articles

Industry

Belgium's association of research-based companies, pharma.be, has called for the government to invest in the pharmaceutical sector, stating that that it could play a key role in stimulating... 2009-06-18


Industry

Belgium drugmaker UCB has received FDA approval to market Cimzia (certolizumab pegol), the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of severe to moderate... 2009-05-15


Industry

US giant Pfizer and Belgium's leading biopharmaceutical company UCB have set up a new company, Cyclofluidics, which will aim to accelerate the drug discovery process. The joint venture... 2008-10-22


Companies

Belgian biopharmaceuticals firm UCB is to shed around 2,000 jobs globally - 17% of its total workforce - as part of a project called Shape, which aims to 'increase focus on its core... 2008-09-02


Industry

Belgium's drug industry association, pharma.be, has defended the price of medicines in the country following local reports suggesting the market is over-priced. Pharma.be also claims... 2008-07-15


Industry

In keeping with Roche's commitment to developing cancer therapies, the company has acquired worldwide exclusive rights to an early stage cancer therapy that is being co-developed... 2008-06-24


Industry

Belgium's efforts to keep drug spending down look as if they are being rewarded, with sales of reimbursed drugs increasing by less than 7% in 2007, within the national health insurance... 2008-02-19


Industry

Employees at Belgium-based drugmaker Janssen Pharmaceutica (Janssen) are striking in protest at the compensation packages being offered to workers recently made redundant by US... 2007-11-20


Industry

Health tourism in Belgium is on the increase as thousands of patients from around Europe flock to the country to take advantage of low treatment costs and excellent facilities. Of... 2007-11-06


Finance

Thousands of Belgian patients could be saved from going blind after US firm Genentech's controversial drug Lucentis (ranibizumab), which treats wet age-related macular degeneration... 2007-10-29

21 to 30 of 45 results
<< | < | 1 | 2 | 3 | 4 | 5 | > | >>
Insight